# Topical Antibiotics and Intravitreous Injections

> **NCT00410891** · PHASE4 · COMPLETED · sponsor: **Stanford University** · enrollment: 129 (actual)

## Conditions studied

- Intravitreous
- Injections

## Interventions

- **DRUG:** gatifloxacin

## Key facts

- **NCT ID:** NCT00410891
- **Lead sponsor:** Stanford University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2009-12
- **Final completion:** 2009-12
- **Target enrollment:** 129 (ACTUAL)
- **Last updated:** 2017-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00410891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00410891, "Topical Antibiotics and Intravitreous Injections". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00410891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
